At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 12, 2026 at 16:32 ET
Dodge & Cox filed an amended Schedule 13G disclosing a 12.3% passive stake in Elanco Animal Health as of September 30, 2026, down from 13.3% in the prior filing. The reduction is modest and consistent with routine portfolio rebalancing by a passive investment manager.
- Dodge & Cox reported beneficial ownership of 61,430,997 shares of Elanco Animal Health common stock as of September 30, 2026
- The stake represents 12.3% of shares outstanding, down from 13.3% in the prior filing (May 2026)
- Dodge & Cox Stock Fund holds 38,409,300 shares or 7.7% of the class
- The filing is a passive Schedule 13G/A under Rule 13d-1(b)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access